Hypolipidaemic effect of maize starch with different amylose content in ovariectomized rats depends on intake amount of resistant starch.
The effect of amylose content on digestibility of starch in the small intestine and on the concentration of plasma lipid were studied in ileorectostomized rats and in ovariectomized rats, respectively. Seven kinds of starch with different amylose content (0, 27, 54, 62, 76, 79, 86 %) were used as test starch, which contained 0.4, 5.6, 37.1, 40.2, 45.6, 36.9 and 36.1 % resistant starch (RS), respectively. Rats were fed one of test diets containing 30 % test starch with different amylose content for 14 d in ileorectostomized and for 21 d in ovariectomized rats. Food intake was not significantly different among the groups. In ileorectostomized rats, the small intestinal starch digestibility decreased with increasing intakes of amylose and RS. In ovariectomized rats, body weight gain was lower on the higher amylose maize starch diets. The concentrations of plasma TAG and cholesterol decreased with increasing intake of RS. The concentrations of liver total lipids and TAG decreased with increasing intake of RS, but that of liver cholesterol did not. There was significant positive correlation between the level of sterol regulatory element-binding protein-1c mRNA and concentration of liver TAG. Total SCFA amount in the caecum increased logarithmically with increasing dry weight of caecal contents. The amount of bile acids in the small intestinal content and the excretions of bile acids and neutral steroids in faeces increased with increasing RS intake. These results show that starch rich in RS is more effective in preventing ovarian hormone deficiency-induced hyperlipidaemia.
Liu
Xiong
X
Department of Biological Resources, Faculty of Agriculture, Ehime University, Matsuyama 790-8566, Japan.
Ogawa
Hiroshi
H
Kishida
Taro
T
Ebihara
Kiyoshi
K
D000688:Amylose / Q000008:administration & dosage* / Q000032:analysis; D000821:Animal Feed; D000818:Animals; D001647:Bile Acids and Salts / Q000032:analysis / Q000235:genetics; D004083:Cholestanol / Q000032:analysis; D004063:Digestion; D004967:Estrogens / Q000172:deficiency*; D005260:Female; D015870:Gene Expression; D007421:Intestine, Small / Q000378:metabolism; D008055:Lipids / Q000032:analysis / Q000097:blood*; D008099:Liver / Q000737:chemistry; D010052:Ovariectomy; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D017208:Rats, Wistar; D013213:Starch / Q000008:administration & dosage* / Q000737:chemistry; D015430:Weight Gain
D001647:Bile Acids and Salts; D004967:Estrogens; D008055:Lipids; D012333:RNA, Messenger; D004083:Cholestanol; D013213:Starch; D000688:Amylose